[HTML][HTML] Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior

V András, J Tomek, N Nagy, L Virág… - Physiological …, 2021 - journals.physiology.org
Cardiac arrhythmias are among the leading causes of mortality. They often arise from
alterations in the electrophysiological properties of cardiac cells and their underlying ionic …

Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-β signaling

W Parichatikanond, T Luangmonkong… - Frontiers in …, 2020 - frontiersin.org
Transforming growth factor-β (TGF-β) is a common mediator of cancer progression and
fibrosis. Fibrosis can be a significant pathology in multiple organs, including the heart. In this …

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

X Wu, L Qian, H Zhao, W Lei, Y Liu, X Xu, J Li… - Ageing research …, 2023 - Elsevier
Fibrosis is a pathological process caused by abnormal wound healing response, which
often leads to excessive deposition of extracellular matrix, distortion of organ architecture …

Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge

J Gutiérrez-Cuevas, A Sandoval-Rodriguez… - Cells, 2021 - mdpi.com
Obesity is defined as excessive body fat accumulation, and worldwide obesity has nearly
tripled since 1975. Excess of free fatty acids (FFAs) and triglycerides in obese individuals …

[HTML][HTML] Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis

Q Su, X Lv - Genomics, 2020 - Elsevier
Non-coding RNA (ncRNA) is a kind of RNA, produced by genomic transcription and does
not encode protein, but can regulate the function of genes, thus widely regulating …

Targeting the renin-angiotensin-aldosterone system in fibrosis

M AlQudah, TM Hale, MP Czubryt - Matrix Biology, 2020 - Elsevier
Fibrosis is characterized by excessive deposition of extracellular matrix components such as
collagen in tissues or organs. Fibrosis can develop in the heart, kidneys, liver, skin or any …

Is the macrophage phenotype determinant for fibrosis development?

L Lis-López, C Bauset, M Seco-Cervera, J Cosín-Roger - Biomedicines, 2021 - mdpi.com
Fibrosis is a pathophysiological process of wound repair that leads to the deposit of
connective tissue in the extracellular matrix. This complication is mainly associated with …

Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar

J Díez, A González, JC Kovacic - Journal of the American College of …, 2020 - jacc.org
Myocardial interstitial fibrosis (MIF) is a histological hallmark of several cardiac diseases that
alter myocardial architecture and function and are associated with progression to heart …

Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti …

SA Antar, MA Saleh, AA Al-Karmalawy - Life Sciences, 2022 - Elsevier
Pirfenidone (PFD) is a non-peptide synthetic chemical that inhibits the production of
transforming growth factor-beta 1 (TGF-β1), tumor necrosis factor-alpha (TNF-α), platelet …

Novel therapies for the treatment of cardiac fibrosis following myocardial infarction

K Raziyeva, Y Kim, Z Zharkinbekov, K Temirkhanova… - Biomedicines, 2022 - mdpi.com
Cardiac fibrosis is a common pathological consequence of most myocardial diseases. It is
associated with the excessive accumulation of extracellular matrix proteins as well as …